Cureus · 2025
Successful Repair of Glaucoma Drainage Device Tube Exposure With a Corneal Patch Graft and Double-Layer Amniotic Membrane: A Case Report.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chee Shew-Fei, Chong Kar-Yong, Haireen Kamaruddin, Zunaina Embong, Ng Kwang-Sheng
Аннотация
Tube exposure is a recognised complication of glaucoma drainage devices (GDD). We report a case of successful repair of GDD tube exposure using a corneal patch graft and double-layer amniotic membrane in a visually precious eye with previous multiple surgeries. A 47-year-old man with juvenile open-angle glaucoma (JOAG) underwent trabeculectomy in both eyes (OU) and two GDD implantations in the right eye (OD). The left eye (OS) trabeculectomy failed, leading to panophthalmitis and evisceration. Six years after the second GDD in the OD, the superonasal tube became exposed (3.8 mm). Initial repair with an amniotic membrane transplant (AMT) failed, leaving the tube partially exposed (3.2 mm) with scarred, stiff conjunctiva but no leakage. Visual acuity (VA) was counting fingers, and intraocular pressure (IOP) was 11 mmHg. Conservative management included autologous serum eye drops, topical antibiotics, oral doxycycline, and a bandage contact lens. After six months, exposure was reduced to 1.0 mm but increased to 2.0 mm by month eight. The patient underwent surgical repair with a corneal patch graft and double-layer AMT. At six months postoperatively, the tube remained fully covered with no conjunctival erosion. Tube exposure is sight-threatening and may lead to endophthalmitis; persistent or recurrent cases can be effectively managed with corneal patch grafting combined with double-layer AMT, providing durable coverage, promoting re-epithelialisation, and allowing assessment of the underlying device.